Translated from the Portuguese original. Read the original (Português)
Bipolar disorder is a mental health condition in which mood, energy, and activity move in episodes: phases of mania or hypomania (elevated, expansive, or irritable mood, with increased energy) that most often alternate with depressive episodes. Between them there are usually periods of stable mood, called euthymia. It is not a lack of character, inconstancy, or "stress": it is a health condition with defined criteria, which needs medical follow-up and has treatment capable of reducing crises and restoring quality of life.
Per the DSM-5-TR, bipolar disorders are characterized by episodes of mania or hypomania — delimited periods of abnormally elevated, expansive, or irritable mood, together with an abnormal increase in energy and activity — usually alternating with depressive episodes. The manic episode lasts at least one week (or less, if it requires hospitalization), is present most of the day nearly every day, and causes marked impairment; the hypomanic episode lasts at least four days and is noticeable to other people, without reaching that degree of impairment. A single manic episode in a person's lifetime is already enough to define bipolar disorder type I.
Episodes, not "mood swings"
In everyday language, "bipolar" has become a nickname for someone who changes mood easily. The clinical picture is something else. In bipolar disorder, mood does not swing from hour to hour: it is organized into episodes, which last days, weeks, or months, change the person's functioning as a whole — sleep, energy, thinking, judgment — and are noticed by the people around them. Between one episode and another, many people spend long periods in euthymia, with mood within their usual range.
Getting irritated easily, having a terrible day, or reacting intensely to a frustration is not bipolar disorder. What sets it apart are the duration, the change from the person's usual way of being, and the impairment the episode causes.
According to the World Health Organization, 1 in every 226 people worldwide — close to 36 million, or about 0.44% of the population — lives with bipolar disorder, in similar proportions between men and women. An independent survey arrives at higher numbers because it measures things differently: that study, conducted in eleven countries with more than 61,000 adults (Merikangas and colleagues, 2011), estimated 0.6% for type I, 0.4% for type II, and an additional 1.4% of presentations below the diagnostic threshold — 2.4% when adding up the entire "bipolar spectrum." This is not a contradiction: the wider the criterion, the higher the count.
The two poles and the middle ground
Understanding bipolar disorder starts with recognizing three different states. Tap the tabs:
Manic episode
Abnormally elevated, expansive, or irritable mood, with clearly increased energy and activity, for at least one week. Alongside it, at least three of the following signs appear (four, if the mood is only irritable):
- inflated self-esteem or grandiosity;
- decreased need for sleep — sleeps little and does not feel tired;
- rapid speech, hard to interrupt;
- racing thoughts, jumping from idea to idea;
- easy distractibility;
- a lot of goal-directed activity, or agitation;
- involvement in risky activities, with high potential for painful consequences — spending, impulsive decisions, exposure.
Mania causes marked impairment, may require hospitalization, and in some cases comes with psychotic symptoms (delusions or hallucinations). It is not "being happy": it is a state that escapes the person's control.
Hypomanic episode
The same signs as mania, to a lesser degree and for at least four consecutive days. The change is noticeable to other people, but does not reach the point of marked impairment, does not bring psychotic symptoms, and does not require hospitalization.
Precisely because of that, hypomania is the piece most often missed: it can be experienced as a "great," productive, and sociable phase. Almost no one seeks help for feeling good — and it is this phase that, left unreported to the clinician, leaves the diagnosis incomplete.
Depressive episode
It looks the same as an episode of depression: at least two weeks of depressed mood and/or loss of pleasure (anhedonia), with changes in sleep, appetite, energy, concentration, and a sense of worthlessness.
In clinical practice, it is the depressive pole that usually brings the person to the office — and, in type II, most of the impairment comes from recurrent depressive episodes. Hence the caution: a presentation that looks like "just depression" may be the depressive phase of bipolar disorder.
The types described in the manuals
The DSM-5-TR describes different presentations within the same group — and the ICD-11 adopts an equivalent grouping. Tap the cards:
The manuals add specifiers, which detail the episode and the course of each case. Two of them appear frequently: mixed features, when symptoms of both poles mix within the same episode (for example, depressed mood with agitation and racing thoughts), and rapid cycling, when there are four or more mood episodes in twelve months.
Type II is not "mild bipolar"The DSM-5-TR is explicit in warning that type II should not be treated as a milder version of type I. Hypomania is less intense than mania, but the weight of the condition comes from recurrent depressive episodes and persistent instability — which can bring as much, or more, impairment to a person's life.
Why the diagnosis usually takes a long time
Bipolar disorder usually begins between adolescence and early adulthood — though it can also appear later, in a person's thirties — and is rarely recognized right away. Three reasons add up:
- the entry point is almost always depression — the first episode that causes distress is depressive, and the diagnosis on record is depression;
- hypomania goes unreported: it usually isn't seen as a problem, so it doesn't come up in conversation unless someone asks;
- memory of the episode is partial — during the depressed phase, it is hard to recall what the accelerated phase was like. That is why evaluation calls for the person's entire life history and, with their authorization, the perspective of people who live with them.
Surveys across several countries find average delays of several years between the first symptoms and the correct diagnosis. This is not a bureaucratic detail: treatment for bipolar disorder is different from treatment for depression, and the wrong name leads to the wrong approach.
Treatment: what works
Bipolar disorder is a chronic, recurrent condition — the goal is not a cure, but control: fewer episodes, shorter and milder episodes, and a life that keeps moving forward between them. What has scientific backing:
- Medication is the foundation. Mood stabilizers — lithium is the most studied, and valproate is also used — and antipsychotics, these mainly in acute episodes, carry the treatment. The physician is who prescribes, monitors, and adjusts it, and part of the care includes periodic lab tests.
- An antidepressant alone is not treatment for bipolar disorder. Guidelines do not recommend an antidepressant as standalone therapy in the depressive phase, because of the risk of switching into mania or hypomania.
- Treatment continues after improvement. The WHO notes that, even in full remission, medication is usually kept up for at least six months — and that is a floor, not a fixed term: the total length of time is a decision for the physician following the case. The goal is to prevent relapse, not to "mask" a symptom.
- Psychosocial interventions added to medication. Psychoeducation (recognizing one's own early warning signs), family intervention, and cognitive behavioral therapy reduce relapses and improve adherence. The NICE guideline recommends structured interventions, designed specifically for bipolar disorder and with a published manual.
- Sleep and routine are part of it. Sleep deprivation is a recognized trigger for switching into mania; regular schedules are part of treatment, not generic advice.
Treating it changes the outcome — and that matters a great deal here: the WHO notes that people with bipolar disorder die, on average, 13 years earlier than the general population. That is why regular follow-up also includes physical health, not only mood.
The case of lithiumAmong the medications used for mood disorders, lithium has the best evidence for reducing suicide risk: a systematic review with meta-analysis of clinical trials published in the BMJ (2013) found this protective effect. It is an old and effective medication, which requires medical follow-up with routine lab tests — and whose prescription is always individualized.
If there are thoughts of death, seek help nowBipolar disorder significantly increases the risk of suicide, and thoughts about death call for immediate care. In Brazil, CVV — Centro de Valorização da Vida (Center for the Appreciation of Life) offers free, confidential support, 24 hours a day, by phone at 188 (and by chat on the CVV website). In an emergency, go to a health service or call SAMU — 192. You do not have to go through this alone — and this risk decreases with treatment.
What does not help
Some common misunderstandings get in the way of people living with the diagnosis:
- using "bipolar" as an adjective for an inconstant person or for unstable weather — it trivializes a health condition;
- treating mania as a "good phase" to be enjoyed: it disrupts life, finances, and relationships;
- stopping medication on one's own when feeling well — this is one of the most frequent causes of relapse. Any change should be discussed with the physician following the case;
- demanding "willpower": neither the manic nor the depressive episode resolves by decision;
- relying on alcohol or other drugs to "regulate" mood: they interfere with treatment and with medical follow-up.
Test your understanding
Quick quiz
Three questions to reinforce the concept. You'll see the explanation right away.
Further reading
- American Psychiatric Association. DSM-5-TR: Diagnostic and Statistical Manual of Mental Disorders. 5th ed., text revision, 2022.
- World Health Organization (WHO). Bipolar disorder — Fact sheet, 2026.
- World Health Organization (WHO). ICD-11: International Classification of Diseases, chapter on mental, behavioral, and neurodevelopmental disorders.
- Merikangas K. R. et al. "Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative". Archives of General Psychiatry, 2011.
- Cipriani A. et al. "Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis". BMJ, 2013.
- National Institute for Health and Care Excellence (NICE). Bipolar disorder: assessment and management (CG185), 2014, with updates.
- Merck Manual (professional edition) — entry on Bipolar Disorders, with DSM-5-TR criteria summarized for clinical practice (accessed 2026).
- Centro de Valorização da Vida (CVV) — emotional support and suicide prevention, 24h, phone 188 (Brazil).
This entry is educational and does not replace assessment, diagnosis or treatment by a qualified health professional. Every person is unique — for a specific case, seek individual guidance.